[Clinical results of a rokitamycin dry syrup in pediatric infections]. 1988

K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
Department of Pediatrics, School of Medicine, Hirosaki University.

Clinical efficacies of a new macrolide antibiotic, rokitamycin (RKM, TMS-19-Q), were studied in acute pediatric infections. Responses to the RKM administration were evaluable in 62 out of 68 patients consisted of 7 patients with pharyngitis (efficacy rate of 85.7%, 6/7 patients), 4 with bronchitis (25.0%, 1/4), 9 with tonsillitis (100%, 9/9), 13 with mycoplasmal pneumonia (100%, 13/13), 13 with hemolytic streptococcal infections (92.3%, 12/13), 14 with pneumonia (57.1%, 8/14), one with pertussis (100%, 1/1) and another with Chlamydia pneumonia (100%, 1/1) thus an overall efficacy rate of 82.3% was achieved. Urticaria was observed in one of the patients as an adverse reaction to the drug, while abnormal laboratory test results were noted in 3 patients, but none of such changes were severe. The drug, even when administered in combination with a theophylline preparation, exerted no effects on the serum concentration of the latter.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007933 Leucomycins An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
July 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
July 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
October 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
July 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
July 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
June 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
June 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
October 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
July 1988, The Japanese journal of antibiotics,
K Kawauchi, and Y Sato, and S Kimura, and S Yonesaka, and M Yokoyama, and A Onishi, and T Asuka, and T Okamoto, and Y Takebe, and T Tsushima
July 1989, The Japanese journal of antibiotics,
Copied contents to your clipboard!